作者
Johanne Silvain,Guillaume Cayla,Farzin Beygui,Grégoire Range,Benoît Lattuca,Jean-Philippe Collet,Jean‐Guillaume Dillinger,Ziad Boueri,Philippe Brunel,Christophe Pouillot,Franck Boccara,L Christiaens,Jean-Noël Labeque,Thibault Lhermusier,Jean-Louis Georges,Anne Bellemain-Appaix,Hervé Breton,Marie Hauguel‐Moreau,Christophe Saint‐Etienne,Christophe Caussin,François Jourda,Zuzana Moťovská,Paul Guedeney,Mohamad El Kasty,Mikaël Laredo,Raphaëlle Dumaine,Grégory Ducrocq,Éric Vicaut,Gilles Montalescot
摘要
Clopidogrel associated with aspirin is the recommended treatment for patients undergoing elective percutaneous coronary intervention (PCI). Although severe PCI-related events are rare, evidence suggests that PCI-related myocardial infarction and myocardial injury are frequent complications that can impact the clinical prognosis of the patients. Antiplatelet therapy with a potent P2Y